Dalriada Therapeutics

www.dalriadatx.com
Innovation Type:
Therapeutics
Cancer Type:
Heme
Funding Stage:
Seed
Fund:
Prospects
Development of DT-1 Class of Small Molecules for the Treatment of Leukemia

Related news

    CONNECT WITH FACIT

    Learn more about how we are driving made-in-Ontario oncology innovations reach the market.